GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Treatment com AI Inc (XCNQ:TRUE) » Definitions » Float Percentage Of Total Shares Outstanding

Treatment com AI (XCNQ:TRUE) Float Percentage Of Total Shares Outstanding : 0.00% (As of May. 17, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Treatment com AI Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Treatment com AI's float shares is 0.00 Mil. Treatment com AI's total shares outstanding is 58.00 Mil. Treatment com AI's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Treatment com AI's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Treatment com AI's Institutional Ownership is 0.00%.


Treatment com AI Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Treatment com AI's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/58.00
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Treatment com AI Business Description

Industry
Traded in Other Exchanges
Address
838 West Hastings Street, Suite 700, Vancouver, BC, CAN, V6C 0A6
Treatment com AI Inc operates in the business of providing personalized health care information that is relevant and trustworthy empowering patients to make responsible, informed decisions about their health while improving communications, reducing costs and in-clinic wait times for medical practitioners.
Executives
Essam Hamza Director, Senior Officer